BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29335830)

  • 1. From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence.
    Zygogianni A; Protopapa M; Kougioumtzopoulou A; Simopoulou F; Nikoloudi S; Kouloulias V
    Clin Transl Oncol; 2018 Aug; 20(8):989-1003. PubMed ID: 29335830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating recurrent glioblastoma: an update.
    Kamiya-Matsuoka C; Gilbert MR
    CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Hypoxia and Alterations in Microvascular Architecture Predict Glioblastoma Recurrence in Humans.
    Stadlbauer A; Kinfe TM; Eyüpoglu I; Zimmermann M; Kitzwögerer M; Podar K; Buchfelder M; Heinz G; Oberndorfer S; Marhold F
    Clin Cancer Res; 2021 Mar; 27(6):1641-1649. PubMed ID: 33293375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
    Lawton CD; Nagasawa DT; Yang I; Fessler RG; Smith ZA
    J Neurosurg Spine; 2012 Nov; 17(5):438-48. PubMed ID: 22958073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma: Overview of Disease and Treatment.
    Davis ME
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent glioblastoma multiforme: a review of natural history and management options.
    Hou LC; Veeravagu A; Hsu AR; Tse VC
    Neurosurg Focus; 2006 Apr; 20(4):E5. PubMed ID: 16709036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
    Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
    Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Glioblastoma.
    Alexander BM; Cloughesy TF
    J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
    Weinberg BD; Boreta L; Braunstein S; Cha S
    J Neurooncol; 2018 Jul; 138(3):549-556. PubMed ID: 29546530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.
    von Neubeck C; Seidlitz A; Kitzler HH; Beuthien-Baumann B; Krause M
    Br J Radiol; 2015 Sep; 88(1053):20150354. PubMed ID: 26159214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
    Bambury RM; Morris PG
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.
    Batash R; Asna N; Schaffer P; Francis N; Schaffer M
    Curr Med Chem; 2017; 24(27):3002-3009. PubMed ID: 28521700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review.
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Hassan SSU
    Biomed Pharmacother; 2017 Aug; 92():681-689. PubMed ID: 28582760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status and prospect in the treatment of glioblastoma].
    Jiang HH; Lin S
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):70-74. PubMed ID: 31902174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions.
    Corso CD; Bindra RS
    Semin Radiat Oncol; 2016 Oct; 26(4):281-98. PubMed ID: 27619250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
    Mirza FA; Shamim MS
    J Pak Med Assoc; 2018 Oct; 68(10):1543-1545. PubMed ID: 30317361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.